At a glance
ClinicalIndex Comparison RecordN/ACompleted· 32 enrolled
Drug / intervention
everlinQ endoAVF Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
everlinQ Endovascular Access System Enhancements (EASE) Study
In Brief
A clinical study evaluating everlinQ endoAVF System for Chronic Kidney Diseases. Completed, enrolled 32 participants.
Detailed Summary
Prospective, single-center study to evaluate the everlinQ System when used to create an endoAVF in hemodialysis patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Kidney Diseases
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJul 2015
Primary CompletionJun 2017
First PostedOct 2018
TodayJul 2026
First PostedOct 17, 2018
Enrollment StartJul 27, 2015
Primary CompletionJun 19, 2017
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 7.7 years ago
Interventions
everlinQ endoAVF Systemdevice